Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
(1)
,
(1)
,
(1)
,
(1)
,
(2)
,
(1)
,
(3)
,
(4)
,
(5)
,
(6)
,
(1)
,
(1)
,
(1)
,
(1)
,
(7)
,
(5)
,
(8)
,
(8)
,
(9)
,
(1)
,
(1)
,
(1)
,
(1)
,
(1)
,
(10)
,
(11)
,
(7)
,
(1)
,
(3)
,
(8)
,
(12)
,
(12)
,
(6)
,
(6)
,
(3)
,
(5)
,
(13)
,
(14)
,
(10)
,
(15)
,
(15)
,
(7)
,
(7)
,
(7)
,
(7)
,
(1)
,
(6)
,
(4)
,
(2)
,
(5)
,
(1)
,
(4)
,
(1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Lucille Stuani
- Function : Author
- PersonId : 802395
- ORCID : 0000-0001-6116-981X
Marie Sabatier
- Function : Author
- PersonId : 793506
- ORCID : 0000-0001-7673-4842
Estelle Saland
- Function : Author
- PersonId : 764704
- ORCID : 0000-0001-8521-3061
Guillaume Cognet
- Function : Author
- PersonId : 802402
- ORCID : 0000-0001-5427-8110
Nathalie Poupin
- Function : Author
- PersonId : 737096
- IdHAL : nathalie-poupin
- ORCID : 0000-0002-3393-1405
- IdRef : 169457826
Claudie Bosc
- Function : Author
- PersonId : 784321
- ORCID : 0000-0003-1435-3475
Florence A Castelli
- Function : Author
- PersonId : 808445
- ORCID : 0000-0002-6886-8549
Lara Gales
- Function : Author
- PersonId : 976067
- ORCID : 0000-0002-1233-2032
Evgenia Turtoi
- Function : Author
- PersonId : 802398
- ORCID : 0000-0003-3075-3006
Camille Montersino
- Function : Author
- PersonId : 784324
- ORCID : 0000-0001-7024-5327
Thomas Farge
- Function : Author
- PersonId : 784319
- ORCID : 0000-0002-4390-8073
Emeline Boet
- Function : Author
- PersonId : 802397
- ORCID : 0000-0002-7718-8692
Nicolas Broin
- Function : Author
- PersonId : 784322
- ORCID : 0000-0003-3648-8426
Clément Larrue
- Function : Author
- PersonId : 784030
- ORCID : 0000-0001-5827-8433
Natalia Baran
- Function : Author
- PersonId : 802399
- ORCID : 0000-0003-0618-4798
Madi y Cissé
- Function : Author
- PersonId : 797015
- ORCID : 0000-0001-6760-3381
Marc Conti
- Function : Author
- PersonId : 761593
- ORCID : 0000-0003-4208-3492
Sylvain Loric
- Function : Author
- PersonId : 760738
- ORCID : 0000-0002-3715-8827
Tony Kaoma
- Function : Author
- PersonId : 784323
- ORCID : 0000-0002-1269-4826
Alexis Hucteau
- Function : Author
- PersonId : 806469
- ORCID : 0000-0002-7517-7105
Aliki Zavoriti
- Function : Author
- PersonId : 802403
- ORCID : 0000-0002-7994-4439
Ambrine Sahal
- Function : Author
- PersonId : 806470
- ORCID : 0000-0003-4755-2884
Pierre-Luc Mouchel
- Function : Author
- PersonId : 801971
- ORCID : 0000-0001-7832-9146
Mathilde Gotanègre
- Function : Author
- PersonId : 798825
- ORCID : 0000-0003-4764-2142
Cédric Cassan
- Function : Author
- PersonId : 802400
- ORCID : 0000-0003-3022-4278
Feng Wang
- Function : Author
- PersonId : 757703
- ORCID : 0000-0001-8281-7978
Mohsen Hosseini
- Function : Author
- PersonId : 784320
- ORCID : 0000-0002-1686-8512
Emeline Chu-Van
- Function : Author
- PersonId : 791338
- ORCID : 0000-0003-1827-2138
Laurent Le Cam
- Function : Author
- PersonId : 766960
- ORCID : 0000-0003-0325-878X
- IdRef : 096645474
Martin Carroll
- Function : Author
- PersonId : 784325
- ORCID : 0000-0002-5622-3735
Mary A Selak
- Function : Author
- PersonId : 822299
- ORCID : 0000-0003-3029-0021
Norbert Vey
- Function : Author
- PersonId : 762211
- ORCID : 0000-0001-7027-040X
Rémy Castellano
- Function : Author
- PersonId : 759966
- ORCID : 0000-0002-0152-985X
François Fenaille
- Function : Author
- PersonId : 778143
- ORCID : 0000-0001-6787-4149
- IdRef : 089320964
Andrei Turtoi
- Function : Author
- PersonId : 774643
- ORCID : 0000-0003-3813-6635
Guillaume Cazals
- Function : Author
- PersonId : 758886
- ORCID : 0000-0002-4793-3217
Pierre Bories
- Function : Author
- PersonId : 768478
- ORCID : 0000-0002-2252-0395
Yves Gibon
- Function : Author
- PersonId : 740806
- IdHAL : yves-gibon
- ORCID : 0000-0001-8161-1089
- IdRef : 157631621
Brandon Nicolay
- Function : Author
- PersonId : 802404
- ORCID : 0000-0002-6849-1200
Sébastien Ronseaux
- Function : Author
- PersonId : 802405
- ORCID : 0000-0002-4071-1451
Joseph R Marszalek
- Function : Author
- PersonId : 822300
- ORCID : 0000-0003-2320-3209
Koichi Takahashi
- Function : Author
- PersonId : 783052
- ORCID : 0000-0002-8027-9659
Courtney D Dinardo
- Function : Author
- PersonId : 822301
- ORCID : 0000-0001-9003-0390
Marina Konopleva
- Function : Author
- PersonId : 784877
- ORCID : 0000-0002-9347-2212
Véra Pancaldi
- Function : Author
- PersonId : 774256
- ORCID : 0000-0002-7433-624X
Yves Collette
- Function : Author
- PersonId : 752645
- IdHAL : yves-collette
- ORCID : 0000-0001-5359-7099
- IdRef : 070509891
Floriant Bellvert
- Function : Author
- PersonId : 763226
- IdHAL : floriant-bellvert
- ORCID : 0000-0002-3259-8655
Fabien Jourdan
- Function : Author
- PersonId : 736810
- IdHAL : fabien-jourdan
- ORCID : 0000-0001-9401-2894
- IdRef : 069183996
Laetitia K Linares
- Function : Author
- PersonId : 793507
- ORCID : 0000-0003-1661-2119
Christian Récher
- Function : Author
- PersonId : 758643
- ORCID : 0000-0002-3332-4525
Jean-Charles Portais
- Function : Author
- PersonId : 1097795
- ORCID : 0000-0002-3480-0933
- IdRef : 058637397
Jean-Emmanuel Sarry
- Function : Author
- PersonId : 756167
- ORCID : 0000-0002-6704-2032
Abstract
Mutations in IDH induce epigenetic and transcriptional reprogramming, differentiation bias, and susceptibility to mitochondrial inhibitors in cancer cells. Here, we first show that cell lines, PDXs, and patients with acute myeloid leukemia (AML) harboring an IDH mutation displayed an enhanced mitochondrial oxidative metabolism. Along with an increase in TCA cycle intermediates, this AML-specific metabolic behavior mechanistically occurred through the increase in electron transport chain complex I activity, mitochondrial respiration, and methylation-driven CEBPα-induced fatty acid β-oxidation of IDH1 mutant cells. While IDH1 mutant inhibitor reduced 2-HG oncometabolite and CEBPα methylation, it failed to reverse FAO and OxPHOS. These mitochondrial activities were maintained through the inhibition of Akt and enhanced activation of peroxisome proliferator-activated receptor-γ coactivator-1 PGC1α upon IDH1 mutant inhibitor. Accordingly, OxPHOS inhibitors improved anti-AML efficacy of IDH mutant inhibitors in vivo. This work provides a scientific rationale for combinatory mitochondrialtargeted therapies to treat IDH mutant AML patients, especially those unresponsive to or relapsing from IDH mutant inhibitors.
Domains
Life Sciences [q-bio]
Origin : Publisher files allowed on an open archive